These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1349486)

  • 1. Efficacy of conventional and sustained-release verapamil in stable angina pectoris.
    Pellinen TJ; Lukkala K; Sundberg S; Heikkilä J; Frick MH
    Ann Med; 1992 Feb; 24(1):49-53. PubMed ID: 1349486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized double-blind comparison of the effects of isosorbide dinitrate retard, verapamil sustained-release, and their combination on myocardial ischemic episodes.
    Friedensohn A; Meshulam R; Schlesinger Z
    Cardiology; 1991; 79 Suppl 2():31-40. PubMed ID: 1760827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the antianginal efficacy of isosorbide dinitrate (ISDN) 40 mg and verapamil 120 mg three times daily in the acute trial and following two-week treatment.
    Schneider W; Maul FD; Bussmann WD; Lang E; Hör G; Kaltenbach M
    Eur Heart J; 1988 Feb; 9(2):149-58. PubMed ID: 3280317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which drug to choose for stable angina pectoris: a comparative study between bisoprolol and nitrates.
    van de Ven LL; Vermeulen A; Tans JG; Tans AC; Liem KL; Lageweg NC; Lie KI
    Int J Cardiol; 1995 Jan; 47(3):217-23. PubMed ID: 7721498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina.
    Walker JM; Curry PV; Bailey AE; Steare SE
    Int J Cardiol; 1996 Feb; 53(2):117-26. PubMed ID: 8682597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verapamil administered twice daily in stable angina pectoris.
    Tan AT; Quek S
    Chest; 1984 Jan; 85(1):55-8. PubMed ID: 6360575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of antianginal efficacy of long-acting sustained release isosorbide dinitrate in comparison with short-acting isosorbide dinitrate.
    Rao YV; Reddy KS; Wasir HS
    Indian Heart J; 1991; 43(2):97-100. PubMed ID: 1752623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of controlled-release isosorbide-5-mononitrate as adjunctive treatment to beta-blocking agents in patients with stable angina pectoris.
    Svendsen JH; Aldershvile J; Abildgaard U; Amtorp O
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):358-63. PubMed ID: 2476613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind randomised crossover trial comparing isosorbide dinitrate cream and oral sustained-release tablets in patients with angina pectoris.
    Handler CE; Sullivan ID
    Int J Cardiol; 1985 Feb; 7(2):149-57. PubMed ID: 3882583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination therapy with isosorbide dinitrate and verapamil in patients with coronary heart disease and hypertension: effect on blood pressure, ischemia and left ventricular function].
    Vogler AC; Silber S; Vogel M; Theisen K
    Z Kardiol; 1989; 78 Suppl 2():183-7; discussion 188-9. PubMed ID: 2588761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy combinations in angina pectoris].
    Carù B; De Ponti C; De Biase AM
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():103-9. PubMed ID: 6407433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antianginal efficacy over 24 hours and exercise hemodynamic effects of once daily sustained-release 300 mg diltiazem and 240 mg verapamil in stable angina pectoris.
    De Rosa ML; Giordano A; Melfi M; Della Guardia D; Ciaburri F; Rengo F
    Int J Cardiol; 1998 Jan; 63(1):27-35. PubMed ID: 9482142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-anginal efficacy of a controlled-release formulation of isosorbide-5-mononitrate once daily in angina patients on chronic beta-blockade.
    Uusitalo A; Keyriläinen O; Härkönen R; Rautio P; Rehnqvist N; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G
    Acta Med Scand; 1988; 223(3):219-25. PubMed ID: 2895564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.
    Gunasekara NS; Noble S
    Drugs; 1999 Feb; 57(2):261-77. PubMed ID: 10188765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris.
    Markis JE; Gorlin R; Mills RM; Williams RA; Schweitzer P; Ransil BJ
    Am J Cardiol; 1979 Feb; 43(2):265-71. PubMed ID: 367136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained-release verapamil and nifedipine in exercise-induced angina pectoris.
    Foale RA; Vandenburg MJ
    Eur Heart J; 1992 Feb; 13(2):256-60. PubMed ID: 1555625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation using serial exercise tests of verapamil alone and combined with isosorbide dinitrate in exertional angina].
    Vázquez de Prada JA; Ruano J; Zueco J; Colman T; González-Vílchez F; Pajarón A
    Rev Esp Cardiol; 1989 Oct; 42(8):513-8. PubMed ID: 2602607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained-release and instant-release verapamil in treatment of angina pectoris.
    Jespersen CM; Klitgaard NA; Nielsen H; Hansen JF
    Eur J Clin Pharmacol; 1989; 36(6):625-7. PubMed ID: 2776821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced effectiveness of combined sustained-release forms of isosorbide dinitrate and diltiazem for stable angina pectoris.
    Lehmann G; Reiniger G; Haase HU; Rudolph W
    Am J Cardiol; 1991 Oct; 68(10):983-90. PubMed ID: 1927938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of sustained-release verapamil in chronic stable angina pectoris.
    Weiner DA; Klein MD; Cutler SS
    Am J Cardiol; 1987 Feb; 59(4):215-8. PubMed ID: 3544792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.